AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry
Authors: Davidsson, P Paulson, L Hesse, C Blennow, K Nilsson, CL
Citation: P. Davidsson et al., Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry, PROTEOMICS, 1(3), 2001, pp. 444-452
Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease
Authors: Davidsson, P Bogdanovic, N Lannfelt, L Blennow, K
Citation: P. Davidsson et al., Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease, DEMENT G C, 12(4), 2001, pp. 243-250
The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process
Authors: Sjogren, M Davidsson, P Gottfries, J Vanderstichele, H Edman, A Vanmechelen, E Wallin, A Blennow, K
Citation: M. Sjogren et al., The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process, DEMENT G C, 12(4), 2001, pp. 257-264
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids
Authors: Bjarnadottir, M Nilsson, C Lindstrom, V Westman, A Davidsson, P Thormodsson, F Blondal, H Gudmundsson, G Grubb, A
Citation: M. Bjarnadottir et al., The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids, AMYLOID, 8(1), 2001, pp. 1-10
Identification of proteins from Escherichia coli using two-dimensional semi-preparative electrophoresis and mass spectrometry
Authors: Gustafsson, E Thoren, K Larsson, T Davidsson, P Karlsson, KA Nilsson, CL
Citation: E. Gustafsson et al., Identification of proteins from Escherichia coli using two-dimensional semi-preparative electrophoresis and mass spectrometry, RAP C MASS, 15(6), 2001, pp. 428-432
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
Authors: Davidsson, P Blennow, K Andreasen, N Eriksson, B Minthon, L Hesse, C
Citation: P. Davidsson et al., Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease, NEUROSCI L, 300(3), 2001, pp. 157-160
Transient increase in total tau but not phospho-tau in human cerebrospinalfluid after acute stroke
Authors: Hesse, C Rosengren, L Andreasen, N Davidsson, P Vanderstichele, H Vanmechelen, E Blennow, K
Citation: C. Hesse et al., Transient increase in total tau but not phospho-tau in human cerebrospinalfluid after acute stroke, NEUROSCI L, 297(3), 2001, pp. 187-190
Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry
Authors: Hesse, C Nilsson, CL Blennow, K Davidsson, P
Citation: C. Hesse et al., Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry, ELECTROPHOR, 22(9), 2001, pp. 1834-1837
An operationalization of Stevenson's conceptualization of entrepreneurshipas opportunity-based firm behavior
Authors: Brown, TE Davidsson, P Wiklund, J
Citation: Te. Brown et al., An operationalization of Stevenson's conceptualization of entrepreneurshipas opportunity-based firm behavior, STRAT MANAG, 22(10), 2001, pp. 953-968
Cerebrospinal fluid tau and beta-amyloid((I-42)) in dementia disorders
Authors: Vanmechelen, E Vanderstichele, H Hulstaert, F Andreasen, N Minthon, L Winblad, B Davidsson, P Blennow, K
Citation: E. Vanmechelen et al., Cerebrospinal fluid tau and beta-amyloid((I-42)) in dementia disorders, MECH AGE D, 122(16), 2001, pp. 2005-2011
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease
Authors: Andreasen, N Gottfries, J Vanmechelen, E Vanderstichele, H Davidsson, P Blennow, K Rosengren, L Blennow, K
Citation: N. Andreasen et al., Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease, J NE NE PSY, 71(4), 2001, pp. 557-558
Both total and phosphorylated tau are increased in Alzheimer's disease
Authors: Sjogren, M Davidsson, P Tullberg, M Minthon, L Wallin, A Wikkelso, C Granerus, AK Vanderstichele, H Vanmechelen, E Blennow, K
Citation: M. Sjogren et al., Both total and phosphorylated tau are increased in Alzheimer's disease, J NE NE PSY, 70(5), 2001, pp. 624-630
Tau and A beta 42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values
Authors: Sjogren, M Vanderstichele, H Agren, H Zachrisson, O Edsbagge, M Wikkelso, C Skoog, I Wallin, A Wahlund, LO Marcusson, J Nagga, K Andreasen, N Davidsson, P Vanmechelen, E Blennow, K
Citation: M. Sjogren et al., Tau and A beta 42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values, CLIN CHEM, 47(10), 2001, pp. 1776-1781
Evaluation of CSF-tau and CSF-A beta 42 as diagnostic markers for Alzheimer disease in clinical practice
Authors: Andreasen, N Minthon, L Davidsson, P Vanmechelen, E Vanderstichele, H Winblad, B Blennow, K
Citation: N. Andreasen et al., Evaluation of CSF-tau and CSF-A beta 42 as diagnostic markers for Alzheimer disease in clinical practice, ARCH NEUROL, 58(3), 2001, pp. 373-379
CSF markers for early Alzheimer's disease
Authors: Blennow, K Davidsson, P Vanmechelen, E
Citation: K. Blennow et al., CSF markers for early Alzheimer's disease, ALZHEIMER'S DISEASE, 2001, pp. 275-283
Standardization of measurement of beta-amyloid((1-42)) in cerebrospinal fluid and plasma
Authors: Vanderstichele, H Van Kerschaver, E Hesse, C Davidsson, P Buyse, MA Andreasen, N Minthon, L Wallin, A Blennow, K Vanmechelen, E
Citation: H. Vanderstichele et al., Standardization of measurement of beta-amyloid((1-42)) in cerebrospinal fluid and plasma, AMYLOID, 7(4), 2000, pp. 245-258
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
Authors: Hesse, C Larsson, H Fredman, P Minthon, L Andreason, N Davidsson, P Blennow, K
Citation: C. Hesse et al., Measurement of apolipoprotein E (apoE) in cerebrospinal fluid, NEUROCHEM R, 25(4), 2000, pp. 511-517
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
Authors: Vanmechelen, E Vanderstichele, H Davidsson, P Van Kerschaver, E Van Der Perre, B Sjogren, M Andreasen, N Blennow, K
Citation: E. Vanmechelen et al., Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization, NEUROSCI L, 285(1), 2000, pp. 49-52
Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains
Authors: Blennow, K Bogdanovic, N Heilig, M Grenfeldt, B Karlsson, I Davidsson, P
Citation: K. Blennow et al., Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains, J NEURAL TR, 107(8-9), 2000, pp. 1085-1097
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
Authors: Sjogren, M Minthon, L Davidsson, P Granerus, AK Clarberg, A Vanderstichele, H Vanmechelen, E Wallin, A Blennow, K
Citation: M. Sjogren et al., CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging, J NEURAL TR, 107(5), 2000, pp. 563-579
Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study
Authors: Bogdanovic, N Davidsson, P Volkmann, I Winblad, B Blennow, K
Citation: N. Bogdanovic et al., Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study, J NEURAL TR, 107(4), 2000, pp. 463-478
New separation tools for comprehensive studies of protein expression by mass spectrometry
Authors: Nilsson, CL Davidsson, P
Citation: Cl. Nilsson et P. Davidsson, New separation tools for comprehensive studies of protein expression by mass spectrometry, MASS SPECTR, 19(6), 2000, pp. 390-397
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Authors: Sjogren, M Rosengren, L Minthon, L Davidsson, P Blennow, K Wallin, A
Citation: M. Sjogren et al., Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD, NEUROLOGY, 54(10), 2000, pp. 1960-1964
Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry
Authors: Nilsson, CL Larsson, T Gustafsson, E Karlsson, KA Davidsson, P
Citation: Cl. Nilsson et al., Identification of protein vaccine candidates from Helicobacter pylori using a preparative two-dimensional electrophoretic procedure and mass spectrometry, ANALYT CHEM, 72(9), 2000, pp. 2148-2153
A quantitative and immunohistochemical study on apolipoprotein E in grain tissue in Alzheimer's disease
Authors: Hesse, C Bogdanovic, N Davidsson, P Blennow, K
Citation: C. Hesse et al., A quantitative and immunohistochemical study on apolipoprotein E in grain tissue in Alzheimer's disease, DEMENT G C, 10(6), 1999, pp. 452-459
Risultati: 1-25 | 26-42